As of May 05
| -1.01 / -2.29%|
The 7 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 50.00, with a high estimate of 66.00 and a low estimate of 39.00. The median estimate represents a +15.87% increase from the last price of 43.15.
The current consensus among 8 polled investment analysts is to Hold stock in Agios Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.